Short communication: Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 23, Issue 9, 2007, Pages 1083-1086

  Contreras Galindo, Rafael ^a,b   Almodóvar Camacho, Sharilyn ^a   González Ramírez, Sandra ^a   Lorenzo, Eric ^a   Yamamura, Yasuhiro ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN ENDOGENOUS RETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KINETICS; LONGITUDINAL STUDY; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; RETROVIRUS; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS RESISTANCE; VIRUS TITRATION; BLOOD; DRUG EFFECT; ENDOGENOUS RETROVIRUS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; TREATMENT FAILURE; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ENDOGENOUS RETROVIRUSES; HIV INFECTIONS; HIV-1; HUMANS; KINETICS; LONGITUDINAL STUDIES; RNA, VIRAL; TREATMENT FAILURE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 35348875037     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0054     Document Type: Article

References (18)

1. Löwer R, Löwer J, and Kurth R: The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996;93:5177-5184.
2. Nelson P, Carnegie P, Martin J, Davari E, Hooley P, Roden D, Rowland-Jones S, Warren P, Astley J, and Murray P: Demystified human endogenous retroviruses. Mol Pathol 2003;56:11-18.
3. Bannert N, and Kurth R: Retroelements and the human genome: New perspectives on an old relation. Proc Natl Acad Sci USA 2002;101:14572-14579.
4. Boller K, Konig H, Sauter M, Mueller-Lantzsch N, Lower R, Lower J, and Kurth R: Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 1993;1:349-353.
5. Dewannieux M, Blaise S, and Heidmann T: Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 2005;79:15573-15577.
6. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, and Tristem M: Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA 2004;101:4894-4899.
7. Brodsky I, Foley B, and Gillespie B: Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia. Leuk Lymphoma 1993;11:119-123.
8. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, and Denner J: Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 2005;65:4172-4180.
9. Contreras-Galindo R, Kaplan M, Markovitz D, Lorenzo E, and Yamamura Y: Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2006;22:979-984.
10. Contreras-Galindo R, González M, Almodovar S, González- Ramírez R, Lorenzo E, and Yamamura Y: A new real-time-RTPCR to quantify the human endogenous retrovirus type K (HERVK) RNA load in plasma samples: Increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods 2006;136:51-57.
11. Depil S, Roche C, Dussart P, and Prin L: Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukaemia 2002;16:254-259.
12. Johnston J, Silva C, Holden J, Warren K, Clark A, and Power C: Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann Neurol 2001;50:434-442.
13. Orenstein J: Human endogenous retroviral expression by leukocytes. Ultrastruct Pathol 2000;24:123-124.
14. Stevens R, Baltch A, Smith R, McCreedy B, Michelsen P, Bopp L, and Urnovitz H: Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients. Clin Diagn Lab Immunol 1999;6:783-786.
15. Contreras-Galindo R, Lopez P, Velez R, and Yamamura Y: HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 2007;23:116-122.
16. Siliciano R: Scientific rationale for antiretroviral therapy in 2005: Viral reservoirs and resistance evolution. Top HIV Med 2005;3:96-100.
17. Liang C, and Wainberg MA: The role of Tat in HIV-1 replication: An activator and/or a suppressor? AIDS Rev 2002;4:41-49.
18. Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, Sumpter TR, Robertson N, Jones C, Sauter M, Mueller-Lantzsch N, Debouck C, and Erickson JW: Functional characterization of the protease of human endogenous retrovirus, K10: Can it complement HIV-1 protease? Biochemistry 1998;37:17137-17144.